Recombinant Human SLC1A6 Protein ，GST

SLC1A6, a member of the solute carrier family, is primarily recognized for its role as a high-affinity transporter of neurotransmitters, particularly glutamate and aspartate, across the cellular membrane. This protein is predominantly expressed in the central nervous system and has been implicated in various pathological conditions, including neurodegenerative diseases and psychiatric disorders. Research into SLC1A6 has gained momentum due to its potential as a therapeutic target, as glutamate homeostasis is critical for synaptic function and neuronal health. The reconstitution of SLC1A6 as a recombinant protein allows for the detailed study of its biophysical properties, substrate specificity, and inhibitor interactions. Understanding the structure and function of SLC1A6 can provide insights into the mechanisms underlying neurotransmitter transport and highlight its role in synaptic plasticity and neurotoxicity. Additionally, advancements in cryo-electron microscopy and X-ray crystallography have facilitated the elucidation of the transport mechanism at the molecular level, opening avenues for drug discovery aimed at modulating SLC1A6 activity in various neurological conditions. This growing body of research underscores the significance of SLC1A6 not only as a fundamental transporter but also as a crucial element in potential therapeutic strategies against conditions linked to glutamatergic dysregulation.